tradingkey.logo

Adaptive Biotechnologies Signs Two Immune Receptor Licensing Deals With Pfizer

ReutersDec 15, 2025 2:29 PM

- Adaptive Biotechnologies Corp ADPT.O:

  • ADAPTIVE BIOTECHNOLOGIES ANNOUNCES TWO IMMUNE RECEPTOR LICENSING AGREEMENTS WITH PFIZER

  • ADAPTIVE BIOTECHNOLOGIES CORP - PFIZER TO USE ADAPTIVE'S PLATFORM FOR RHEUMATOID ARTHRITIS

  • ADAPTIVE BIOTECHNOLOGIES CORP - MAY RECEIVE UP TO $890 MILLION IN MILESTONES

  • ADAPTIVE BIOTECHNOLOGIES CORP: SPECIFIC FINANCIAL TERMS OF AGREEMENT WILL NOT BE DISCLOSED

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI